The Source Blog
Recent Action in Pharmaceuticals
W. Va. Code §§ 30-7-15 through 30-7-15E: Registered Professional Nurses – West Virginia
Introduced: Status: Enacted
Scope of practice statutes for registered professional nurses . See definition section § 30-7-1.
Download
W. Va. Code §§ 33-15E-1 through 33-15E-17: Discount Medical Plan Organizations and Discount Prescription Drug Plan Organizations Act – West Virginia
Introduced: Status: Enacted
Statutes contain the Discount Medical Plan Organizations and Discount Prescription Drug Plan Organizations Act.
Download
W. Va. Code §§ 33-50-1 through 33-50-3: Patient Protection and Transparency Act – West Virginia
Introduced: Status: Enacted
Describes the information required to be available online regarding the state’s qualified health plans.
Download
W. Va. Code §§ 16-29G-1 through 16-29G-8: West Virginia Health Information Network – West Virginia
Introduced: Status: Enacted
The purpose of this article is to create the West Virginia Health Information Network under the oversight of the Health Care Authority to promote the design, implementation, operation and maintenance of a fully interoperable statewide […]
Download
S.D. Codified Laws § 58-33-135. Unfair or deceptive practices by pharmacy benefits manager: Unfair Trade Practices – South Dakota
Introduced: Status: Enacted
Statute includes acts or practices by a pharmacy benefits manager that are considered false, misleading, deceptive, or unfair.
Download
S.D. Codified Laws §§ 58-17E-1 through 58-17E-5: Discount Medical Plans – South Dakota
Introduced: Status: Enacted
Definition statutes for Discount Medical Plans chapter.
Download
Wash. Rev. Code §§ 69.41.100 & 69.41.110: Legend Drugs — Prescription Drugs — Substitution of Prescription Drugs – Washington
Introduced: Status: Enacted
Provisions provide legislative recognition and definitions for sections 69.41.100 through 69.41.196.
Download
Previous | Next | See all Legislation Records
Introduced: Status: Enacted
Scope of practice statutes for registered professional nurses . See definition section § 30-7-1.
Download
W. Va. Code §§ 33-15E-1 through 33-15E-17: Discount Medical Plan Organizations and Discount Prescription Drug Plan Organizations Act – West Virginia
Introduced: Status: Enacted
Statutes contain the Discount Medical Plan Organizations and Discount Prescription Drug Plan Organizations Act.
Download
W. Va. Code §§ 33-50-1 through 33-50-3: Patient Protection and Transparency Act – West Virginia
Introduced: Status: Enacted
Describes the information required to be available online regarding the state’s qualified health plans.
Download
W. Va. Code §§ 16-29G-1 through 16-29G-8: West Virginia Health Information Network – West Virginia
Introduced: Status: Enacted
The purpose of this article is to create the West Virginia Health Information Network under the oversight of the Health Care Authority to promote the design, implementation, operation and maintenance of a fully interoperable statewide […]
Download
S.D. Codified Laws § 58-33-135. Unfair or deceptive practices by pharmacy benefits manager: Unfair Trade Practices – South Dakota
Introduced: Status: Enacted
Statute includes acts or practices by a pharmacy benefits manager that are considered false, misleading, deceptive, or unfair.
Download
S.D. Codified Laws §§ 58-17E-1 through 58-17E-5: Discount Medical Plans – South Dakota
Introduced: Status: Enacted
Definition statutes for Discount Medical Plans chapter.
Download
Wash. Rev. Code §§ 69.41.100 & 69.41.110: Legend Drugs — Prescription Drugs — Substitution of Prescription Drugs – Washington
Introduced: Status: Enacted
Provisions provide legislative recognition and definitions for sections 69.41.100 through 69.41.196.
Download
Previous | Next | See all Legislation Records
FTC v. Caremark Rx, Zinc Health Services, et al. – Federal
District Court: Federal Trade Commission Office of Administrative Law Judges Status: Pending
The FTC filed a civil antitrust lawsuit against three of the largest prescription drug benefit managers that administer about 80% of all prescriptions in the […]
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Next | See all Litigation Records
District Court: Federal Trade Commission Office of Administrative Law Judges Status: Pending
The FTC filed a civil antitrust lawsuit against three of the largest prescription drug benefit managers that administer about 80% of all prescriptions in the […]
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Next | See all Litigation Records
News & Opinions
Articles & Reports
Health Affairs
October 8, 2025
New England Journal of Medicine October 4, 2025
Milbank Quarterly September 15, 2025
Review of Evolutionary Political Economony September 3, 2025
New England Journal of Medicine October 4, 2025
Milbank Quarterly September 15, 2025
Review of Evolutionary Political Economony September 3, 2025
Trends in Pharmaceuticals
2019 Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Transparency
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Rate Setting
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Gouging
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Drug Importation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharmacy Gag Clause Regulation
Gag clause regulation includes laws that allow pharmacists to disclose costs to insured patients and those that prohibit pharmacists from collecting more in cost-sharing from the insured patient than the cash price. See The Source’s Spotlight on 2018 State Drug Legislation Part 3 and 2018 legislation chart for more information.
-
Key:
- Enacted
- Considered
- No Legislative Session
PBM Regulation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharma Other
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session